Treatment and outcome in seven children with malignant androgen secreting adrenocortical tumours
| Patient | Metastases | Treatment | Outcome |
|---|---|---|---|
| 4 | Local tumour growth, hepatic, and pulmonary metastases aa | o′p-DDD, vincristine cisplatin, etoposide,cyclophosphamide, carboplatin | Alive 6 months pa |
| 11 | Local tumour growth aa | o′p-DDD | Died 5 months pa |
| 12 | Local tumour growth and hepatic metastases 3.8 years pa | o′p-DDD | Died 4.3 years pa |
| 16 | Hepatic and pulmonary metastases 9 months pa | o′p-DDD, carboplatin, excision of pulmonary metastases | Alive 3.6 years pa |
| 18 | Hepatic and pulmonary metastases 10 months pa | o′p-DDD | Died 1.8 years pa |
| 19 | Local tumour growth aa; pulmonary metastases 3.8 years pa | None | Alive 4.0 years pa |
| 20 | Hepatic and pulmonary metastases 8 months pa | o′p-DDD | Died 1.8 years pa |
aa, at adrenalectomy; pa, postadrenalectomy; o′p-DDD, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-ethane.